GILVOCARCINS, NEW ANTI-TUMOR ANTIBIOTICS .5. BIOSYNTHESIS OF GILVOCARCINS - INCORPORATION OF C-13-LABELED COMPOUNDS INTO GILVOCARCIN AGLYCONES
GILVOCARCINS, NEW ANTI-TUMOR ANTIBIOTICS .5. BIOSYNTHESIS OF GILVOCARCINS - INCORPORATION OF C-13-LABELED COMPOUNDS INTO GILVOCARCIN AGLYCONES
复制标题
DOI：
10.7164/antibiotics.36.1531
复制
发表时间：
1983-01-01
影响因子：
3.3
通讯作者：
TOMITA, F
中科院分区：
文献类型：
--
作者：
TAKAHASHI, K;TOMITA, F
用13C标记的前体研究了gilvocarcins V和M [由Streptomyces gilvotanareus]的糖苷配基的生物合成。糖苷配基是通过乙酸途径形成的，并提出了其生物合成的途径，其中涉及二次加成的烷基。
The biosynthesis of the aglycones of gilvocarcins V and M [by Streptomyces gilvotanareus] was studied with 13C-labeled precursors. The aglycones are formed via the acetate pathway and a route for their biosynthesis is proposed which involves secondary addition of an alkyl group.